Special ReportsAll NewsFDA BriefsOncology IconsThe Targeted PulseVoices from the Field
Conference CoverageConference ListingData Dialogue with the Oncology Brothers
All VideosCase-Based Peer PerspectivesEvolving Paradigms in OncologyExpert Perspective Virtual Tumor BoardInterviewsInvestigator PerspectivesMedical World NewsPersonalized MedicinePivotal Practice Views with the Oncology BrothersPodcastsSpeaking Out
All PublicationsEvolving ParadigmsPeers & Perspectives in OncologyTargeted Therapies in Oncology
CASE-BASED ROUNDTABLEPARTNERS
CME/CEClinical TrialsEventsPrecision Medicine PerspectivesPress ReleasesSponsored ContentTreatment Resources
SUBSCRIBE
BRAIN CANCER
BREAST CANCERBREAST CANCER
GENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERS
GENOMIC TESTINGGENOMIC TESTING
GI CANCERSGI CANCERSGI CANCERSGI CANCERSGI CANCERS
GYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERS
HEAD & NECK CANCERS
HEMATOLOGYHEMATOLOGY
IMMUNOTHERAPYIMMUNOTHERAPY
LEUKEMIASLEUKEMIASLEUKEMIASLEUKEMIAS
LUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCER
LYMPHOMASLYMPHOMASLYMPHOMASLYMPHOMAS
MPNs
MULTIPLE MYELOMA
NTRK GENE FUSIONS
SARCOMA
SKIN CANCERSSKIN CANCERS
THYROID CANCERS
Spotlight -
  • Biomarker-Driven Lung Cancer
  • GIST
  • HER2 Breast Cancer
  • Chronic Lymphocytic Leukemia
  • Small Cell Lung Cancer
  • Renal Cell Carcinoma
BRAIN CANCER
BREAST CANCERBREAST CANCER
GENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERS
GENOMIC TESTINGGENOMIC TESTING
GI CANCERSGI CANCERSGI CANCERSGI CANCERSGI CANCERS
GYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERS
HEAD & NECK CANCERS
HEMATOLOGYHEMATOLOGY
IMMUNOTHERAPYIMMUNOTHERAPY
LEUKEMIASLEUKEMIASLEUKEMIASLEUKEMIAS
LUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCER
LYMPHOMASLYMPHOMASLYMPHOMASLYMPHOMAS
MPNs
MULTIPLE MYELOMA
NTRK GENE FUSIONS
SARCOMA
SKIN CANCERSSKIN CANCERS
THYROID CANCERS
    • CASE-BASED ROUNDTABLE
    • PARTNERS
    • SUBSCRIBE
Advertisement

Treatments for Relapsed and Refractory Multiple Myeloma

home / case-based-peer-perspectives / vij-relapsed-refractory-myeloma

Treatments for Relapsed and Refractory Multiple Myeloma


Multiple Myeloma: A Case Review

EP. 1: Multiple Myeloma: A Case Review

July 30th 2018

Watch


Doublet Regimen for Elderly Patients With MM

EP. 2: Doublet Regimen for Elderly Patients With MM

July 30th 2018

Watch


Frontline Treatment Approaches in Multiple Myeloma

EP. 3: Frontline Treatment Approaches in Multiple Myeloma

July 30th 2018

Watch


Proteasome Inhibitors in Upfront MM Treatment

EP. 4: Proteasome Inhibitors in Upfront MM Treatment

July 30th 2018

Watch


Maintenance Therapy Outcomes in Multiple Myeloma

EP. 5: Maintenance Therapy Outcomes in Multiple Myeloma

July 30th 2018

Watch


Multiple Myeloma: Supportive Care for Elderly Patients

EP. 6: Multiple Myeloma: Supportive Care for Elderly Patients

July 30th 2018

Watch


Symptomatic Relapse and Second-Line Therapy for MM

EP. 7: Symptomatic Relapse and Second-Line Therapy for MM

July 30th 2018

Watch


Triplet Regimens for Relapsed Multiple Myeloma

EP. 8: Triplet Regimens for Relapsed Multiple Myeloma

July 30th 2018

Watch


Toxicity Management in Second-Line Treatment of R/R MM

EP. 9: Toxicity Management in Second-Line Treatment of R/R MM

July 30th 2018

Watch


Individualizing Treatments in Multiple Myeloma

EP. 10: Individualizing Treatments in Multiple Myeloma

July 30th 2018

Watch

About Us
Advertise
Contact Us
CureToday.com
CancerNetwork.com
OncLive.com
OncNursingNews.com
Do Not Sell My Information
Privacy
Terms & Conditions
Editorial Board
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.